Arkema (AKE) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
28 Sep, 2026Executive summary
Q2 2025 sales declined 5.6% year-over-year to €2,395 million, with persistent weak demand in Europe and the US, but growth in Asia and select sectors like batteries, sports, and 3D printing.
EBITDA for Q2 2025 was €364 million, margin at 15.2%, showing resilience in High Performance Polymers and Adhesive Solutions, but sharp declines in Coating Solutions and Intermediates.
Adjusted net income was €118 million (€1.56/share), down 44.9% year-over-year; recurring cash flow was €111 million.
Net debt and hybrid bonds rose to €3,580 million at end-June 2025, with leverage at 2.5x LTM EBITDA.
Major projects in innovative materials and key growth markets are ramping up, with new capacity coming online in the US, China, and Singapore.
Financial highlights
Q2 2025 revenue was €2,395 million, down 5.6% year-over-year; EBITDA fell 19.3% to €364 million, margin at 15.2%.
Adjusted net income was €118 million, or €1.56 per share, down 44.9% year-over-year.
Recurring operating income (REBIT) was €198 million, margin at 8.3%.
Recurring cash flow reached €111 million; free cash flow for Q2 was €91 million.
Net debt and hybrid bonds at €3,580 million; working capital at 17.0% of annualized sales.
Outlook and guidance
2025 EBITDA guidance set at €1.3–1.4 billion, including a €50 million FX headwind; recurring cash flow expected between €300–400 million.
Cost savings target for 2025 raised to €100 million, double the previous annual target.
Additional EBITDA from major projects expected to reach €50 million in 2025 versus 2024, reaffirming €400 million+ target by 2028.
H2 2025 expected to continue with low demand, geopolitical uncertainty, and limited visibility on tariffs.
Continued focus on innovation and sustainable solutions despite macroeconomic and geopolitical headwinds.
Latest events from Arkema
- Q2 2026 saw strong growth in adhesives and coatings, supporting a positive full-year outlook.AKE
Investor presentation - EBITDA rose 7.4% to €391M, with margin at 16.1%, led by Adhesives, Coatings, and innovation.AKE
Q2 2026 - Resilient 2025 results, strategic investments, and strong governance marked the AGM.AKE
AGM 2026 - Stable volumes and Specialty growth offset lower sales; 2026 EBITDA growth targeted.AKE
Q1 2026 - EBITDA reached €1,251m with strong cash flow and resilience in key growth markets.AKE
Q4 2025 - Q3 2024 EBITDA rose 5.4% to €407 million, margin at 17.0%, amid weak demand and tight debt control.AKE
Q3 2024 - Q2 2024 EBITDA rose 8.2% to €451m on 3.8% sales growth; guidance set at €1.53–1.63bn.AKE
Q2 2024 - Sales rose 1.7% with resilient specialty materials, but profits fell; H2 improvement expected.AKE
Q1 2025 - 2024 EBITDA rose 2.1% to €1.53bn, with Specialty Materials and Asia driving growth.AKE
Q4 2024